The European Assn. for Medical Devices of Notified Bodies says that the number of new CE Mark certificates have dropped significantly in recent years.
MASSDEVICE ON CALL — European regulators have become increasingly coy with their CE Markings, especially for new medical devices, according to a report by the European Assn. for Medical Devices of Notified Bodies, or TEAM-NB.
A survey comparing data from 2010 to 2012 showed a decrease in CE Mark certificates overall and a "significant" decrease in new CE Marks, TEAM-NB reported. The trends are consistent among Europe-based as well as non-European companies, they added.
Low risk prostate cancer is increasingly over-treated, study says
A recent study reported that advanced treatments for prostate cancer are on the rise, even in patients that are not likely to benefit from a more aggressive procedure.
The authors pegged this trend to direct-to-consumer advertisements and fee-for-service medical payments. The uptick in advanced radiation and surgical treatments has many concerned about over-treatment of a manageable, low-risk disease.
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-...
Reva Medical begins enrolling patients in Europe for a trial of its Fantom bioresorbable stent.
A subcommittee of the U.S. Senate's powerful Finance Committee holds a hearing on the medical device...
Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to...